| 000 | 01641 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511181400.0 | ||
| 264 | 0 | _c19921123 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0001-5555 | ||
| 024 | 7 |
_a102340/0001555572297300 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHansen, K | |
| 245 | 0 | 0 |
_aRoxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. _h[electronic resource] |
| 260 |
_bActa dermato-venereologica _cAug 1992 |
||
| 300 |
_a297-300 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aErythema Chronicum Migrans _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGerbillinae |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLyme Disease _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPenicillin V _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRoxithromycin _xtherapeutic use |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 | _aSweden |
| 700 | 1 | _aHovmark, A | |
| 700 | 1 | _aLebech, A M | |
| 700 | 1 | _aLebech, K | |
| 700 | 1 | _aOlsson, I | |
| 700 | 1 | _aHalkier-Sørensen, L | |
| 700 | 1 | _aOlsson, E | |
| 700 | 1 | _aAsbrink, E | |
| 773 | 0 |
_tActa dermato-venereologica _gvol. 72 _gno. 4 _gp. 297-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/102340/0001555572297300 _zAvailable from publisher's website |
| 999 |
_c1364393 _d1364393 |
||